%0 Journal Article %A J. Comin %A D. Kallmes %T Clopidogrel (Plavix) %D 2011 %R 10.3174/ajnr.A2913 %J American Journal of Neuroradiology %X SUMMARY: Clopidogrel is an inhibitor of platelet aggregation, indicated for the prevention of ischemic stroke and in-stent thrombosis. However, it has a number of drawbacks, including an increased risk of hemorrhage; a clinical effect that is slow in onset and irreversible; a genetically determined variability in its clinical potency; and interactions with other commonly administered drugs. Abbreviations Act-Metactive metabolite of clopidogrelADPadenosine diphosphateAHAAmerican Hospital AssociationGIgastrointestinalGPIIb/IIIaglycoprotein IIb/IIIaPPIproton pump inhibitorVWFvon Willebrand factor %U https://www.ajnr.org/content/ajnr/early/2011/12/01/ajnr.A2913.full.pdf